Vivaglobin (Historically referenced; newer 16.5% products have largely superseded it in the Indian context)

Home > Human Normal Immunoglobulin (16.5% w/v) > Vivaglobin (Historically referenced; newer 16.5% products have largely superseded it in the Indian context)

🏷ī¸ Product Details

Manufacturer: Previously CSL Behring (Global). Indian market now dominated by other brands.

Form: Solution for subcutaneous infusion

Strength: 16% (Approx.)

Price: High-cost therapy.

Check Availability

ℹī¸ Why is it prescribed?

Vivaglobin (Historically referenced; newer 16.5% products have largely superseded it in the Indian context) contains Human Normal Immunoglobulin (16.5% w/v). It is primarily used for:

  • Replacement therapy in Primary Immunodeficiency Diseases (PIDD) e.g., X-linked agammaglobulinemia, Common Variable Immunodeficiency (CVID), Severe Combined Immunodeficiency (SCID)
  • Maintenance therapy in Multifocal Motor Neuropathy (MMN) to improve muscle strength and disability

⚠ī¸ Important Safety Information

Side Effects

  • Local reactions at infusion site: pain, erythema, swelling, itching, induration (occur in >5% of patients)
  • Mild systemic reactions: headache, fatigue, fever, chills, nausea, myalgia, arthralgia

Contraindications

  • History of anaphylactic or severe systemic reaction to Human Normal Immunoglobulin or any excipient
  • Patients with selective IgA deficiency who have antibodies against IgA and a history of hypersensitivity

🔄 Substitutes & Alternatives

Other medicines with the same composition (Human Normal Immunoglobulin (16.5% w/v)):

Intaglob SC 16.5% Generic versions supplied to hospitals


Disclaimer: Data is for informational purposes only. Consult a doctor before use.